Exalt Diagnostics Overview

  • Founded
  • 2012
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Exalt Diagnostics General Information

Description

Developer of photonic crystal enhanced fluorescence technology designed to introduce high sensitivity, and highly portable biosensor detection instrumentation to point of care clinics and to consumers. The company's FluoroBoost technology measures the presence and concentration of dozens of proteins circulating inside an individual and offers nanostructured photonic crystal chips and detection instrument that boost the output of fluorescent light emitters used to label DNA and protein molecules present in blood samples, enabling doctors to identify the presence of diseases, such as cancer, that may not become evident until serious symptoms occur.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Commercial Products
Other Industries
Biotechnology
Primary Office
  • 60 Hazelwood Drive
  • Champaign, IL 61820
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Exalt Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Aug-2017 Completed Out of Business
3. Grant 15-Sep-2013 Completed Startup
2. Early Stage VC Completed Startup
1. Accelerator/Incubator Completed Startup
To view Exalt Diagnostics’s complete valuation and funding history, request access »

Exalt Diagnostics Executive Team (1)

Name Title Board Seat Contact Info
Brian Cunningham Ph.D President & Founder
To view Exalt Diagnostics’s complete executive team members history, request access »